Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
Malaria Journal|June 13, 2008
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan childrenCatherine Maiteki-Sebuguzi, Prasanna Jagannathan, Vincent M Yau, et al.Plos One|January 7, 2014
Uptake of community-based HIV testing during a multi-disease health campaign in rural UgandaGabriel Chamie, Dalsone Kwarisiima, Tamara D Clark, et al.Current Developments in Nutrition|May 23, 2020
Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral TherapyJulia L Finkelstein, Heather S Herman, Albert Plenty, et al.Lancet (London, England)|March 27, 2019
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trialRichard Kajubi, Teddy Ochieng, Abel Kakuru, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2019
A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and KenyaJames Ayieko, Maya L Petersen, Edwin D Charlebois, et al.The Journal of Infectious Diseases|June 25, 2014
Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant womenPaul Natureeba, Veronica Ades, Flavia Luwedde, et al.Open Forum Infectious Diseases|July 7, 2018
Effect of a Patient-Centered Phone Call by a Clinical Officer at Time of HIV Testing on Linkage to Care in Rural KenyaJames Ayieko, Maya L Petersen, Annelies van Rie, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapyCatherine A Koss, Paul Natureeba, Albert Plenty, et al.The Lancet. Infectious Diseases|July 17, 2019
Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trialMary K Muhindo, Prasanna Jagannathan, Abel Kakuru, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2014
Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan childrenAbel Kakuru, Jane Achan, Mary K Muhindo, et al.Pageof 10